- Report
- April 2023
- 114 Pages
Global
From €4509EUR$4,750USD£3,804GBP
- Report
- September 2023
- 200 Pages
Global
From €3417EUR$3,599USD£2,882GBP
- Report
- March 2022
- 172 Pages
Global
From €3524EUR$3,712USD£2,972GBP
- Book
- September 2022
- 480 Pages
- Book
- December 2016
- 528 Pages
- Book
- November 2020
Global

Sudden Cardiac Death (SCD) is a major cause of mortality in the field of cardiology. It is defined as an unexpected death due to cardiac arrest, occurring within one hour of the onset of symptoms. SCD is often caused by ventricular fibrillation, a condition in which the heart's electrical activity becomes chaotic and the heart is unable to pump blood. SCD is a major public health concern, as it is the leading cause of death in the United States and other developed countries.
SCD is a growing market, with a variety of products and services available to help diagnose and treat the condition. These include implantable cardioverter defibrillators (ICDs), which are used to detect and treat ventricular fibrillation, as well as other devices such as pacemakers and cardiac monitors. Additionally, there are a number of pharmaceuticals available to treat SCD, such as antiarrhythmic drugs and anticoagulants.
Some companies in the SCD market include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and Biotronik. Show Less Read more